Gary Charles Robb sold $556K of Corcept Therapeutics Incorporated (CORT)

Executed Jan 2 2025, disclosed Jan 6 2025, 4 days later.

Value, as filed

$556K

11,000 sh × $50.50

Executed

Jan 2 2025

the trade date, as filed

Disclosed

Jan 6 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Gary Charles Robb Chief Business Officer profile →

Gary Charles Robb (Chief Business Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $1.2M of CORT (10,000 sh × $116.26, as filed), executed Aug 17.

The name

CORT

Corcept Therapeutics Incorporated CORT · Healthcare · 103 filings in 24 months ticker →

Healthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Gary Charles Robb in CORT

CORTSALE Corcept Therapeutics Incorporated $1.2M
10,000 sh × $116.26
Exec Aug 17
Filed Aug 18 · 4:30 PM ET CORTSALE Corcept Therapeutics Incorporated $166K
2,326 sh × $71.27
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $225K
3,185 sh × $70.77
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $173K
2,279 sh × $75.85
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $147K
2,609 sh × $56.20
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated $509K
11,000 sh × $46.28
Exec Oct 1 2024
Filed Oct 1 2024 · 5:30 PM ET